stocksBOROSCI
BOROSCI

Borosil Scientific Ltd.

Industry Group: Industrial Products
160.75-0.3 (-0.16%)
17 Jul, 12:00 AM

Income Statement

Abridged
Understanding Income Statement
Borosil Scientific Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
AR
12M
AR
12M
PRESS
Total Revenue
394.58438.49467.34
Cost of Operating Revenue
228.64248.42186.08
Gross Profit
165.94190.07281.26
Gross Margin
42.143.360.2
Total Operating Expenses
365.68404.22424.39
Operating Profit
28.9034.2642.95
Operating Margin
7.37.89.2
Financing Income/(Expense) - Net
0.552.77-1.13
Profit before Taxes
31.5540.3942.84
Income Taxes
8.0713.678.26
Profit after Tax
23.5626.8034.61
PAT Margin
6.06.17.4
EPS - Basic - ex Extraordinary Items
2.653.023.89
EPS - Diluted - ex Extraordinary Items
2.653.023.89
EBIT
28.9034.2642.95
EBITDA
45.3552.7462.19
EBITDA Margin
11.512.013.3

Balance Sheet

Abridged
Understanding Balance Sheet
Borosil Scientific Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
2024
Mar 31
2025
Mar 31
2026
Mar 31
Source:
AR
AR
PRESS
Total Current Assets
290.56309.95335.40
Long-Term Investments
0.040.102.40
Property Plant & Equipment - Net
124.62121.47130.41
Total Non-Current Assets
202.63198.98213.68
Total Assets
493.18508.93549.08
Total Current Liabilities
99.9987.1392.78
Long Term Debt
4.801.741.34
Total Non-Current Liabilities
17.0017.2014.81
Total Liabilities
116.99104.33107.59
Total Shareholders' Equity
375.90404.39441.31
Minority Interest
0.300.220.19
Total Equity
376.20404.60441.49
Total Liabilities & Equity
493.18508.93549.08

Cash Flow

Abridged
Understanding Cash Flow Statement
Borosil Scientific Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
AR
12M
AR
12M
PRESS
Operating CF bef Changes in Working Cap
32.6147.6644.02
Working Capital - Increase/(Decrease)
-4.5772.11-1.56
Net CF from Operating Activities
28.04119.7642.46
Capital Expenditures - Net
12.7513.9327.53
Net CF from Investing Activities
-2.80-116.72-37.55
Stock - Issuance/(Retirement) - Net
0.051.560.15
Debt - LT & ST - Issuance/(Retirement) - Total
-14.10-3.40-6.49
Net Cash Flow from Financing Activities
-13.68-1.85-5.06
Free Cash Flow to Equity
1.19102.448.44
Free Operating CF net dividend
15.17105.6014.01
Free Operating CF
15.17105.6014.01

Business Segment Analysis

FY End:
Mar 25

Borosil Scientific Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex
Total₹ 19Cr
Scientific Laboratory Glass & equipment and process system (48.4%)₹ 9.24 CrGlassware (25.8%)₹ 4.92 CrGlassware (25.8%)₹ 4.92 CrUn allocated (0.0%)₹ 0.00 Cr
Revenue / Sales
Total₹ 567Cr
Scientific Laboratory Glass & equipment and process system (54.7%)₹ 309.90 CrGlassware (21.8%)₹ 123.73 CrGlassware (21.8%)₹ 123.73 CrOthers (0.9%)₹ 4.85 CrOthers (0.9%)₹ 4.85 Cr
Assets
Total₹ 623Cr
Scientific Laboratory Glass & equipment and process system (33.0%)₹ 205.27 CrUn allocated (30.5%)₹ 189.77 CrGlassware (17.8%)₹ 111.10 CrGlassware (17.8%)₹ 111.10 CrOthers (0.4%)₹ 2.79 CrOthers (0.4%)₹ 2.79 Cr

Regional Segment Analysis

FY End:
Mar 25

Borosil Scientific Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales
Total₹ 438Cr
India (85.2%)₹ 373.61 CrOutside India (14.8%)₹ 64.88 Cr

Historical Segment Analysis

Track how Borosil Scientific Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Business
2024
Mar 31
2025
Mar 31
Scientific Laboratory Glass & equipment and process system79
Glassware65
Glassware 65
Un allocated00

Frequently Asked Questions

What is the revenue of Borosil Scientific Ltd.?
The latest trailing twelve month revenue of Borosil Scientific Ltd. is ₹ 467.34 Cr, reflecting a 1-year growth of 6.58%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Borosil Scientific Ltd.?
The latest trailing twelve month net profit (PAT) of Borosil Scientific Ltd. is ₹ 34.61 Cr. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Borosil Scientific Ltd.?
The trailing twelve month EBITDA of Borosil Scientific Ltd. is approximately ₹ 42.95 Cr (based on an operating margin of 9.19%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Borosil Scientific Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Borosil Scientific Ltd. is 3.89. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Borosil Scientific Ltd.?
The debt-to-equity ratio of Borosil Scientific Ltd. stands at 0.02. The interest coverage ratio is 38.08x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Borosil Scientific Ltd.?
The estimated book value per share of Borosil Scientific Ltd. is 49.61 (derived from a P/B ratio of 3.24 and market price of ₹ 160.75), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Borosil Scientific Ltd.?
The trailing twelve month operating cash flow of Borosil Scientific Ltd. is ₹ 42.46 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Borosil Scientific Ltd. report consolidated or standalone financials?
Borosil Scientific Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.